Tracy Brandmeyer
Co-Founder & Chief Executive Officer Cognigenics
Seminars
Wednesday 3rd February 2027
Leveraging Intranasal RNA Therapeutics to Target CNS Circuits Beyond the Blood-Brain Barrier
11:00 am
- Explore how intranasal RNA therapies can enable targeted modulation of neural circuits while avoiding systemic exposure
- Understand the opportunities and challenges of delivering RNA therapeutics directly to the brain through nose-to-brain pathways
- Learn how next-generation genetic medicines may unlock new treatment approaches for cognitive, psychiatric, and neurodegenerative disorders
